Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sequoia Pharmaceuticals Inc.
DescriptionCytochrome P450 3A4 (CYP3A4) inhibitor
Molecular Target Cytochrome P450 3A4 (CYP3A4)
Mechanism of ActionCytochrome P450 3A (CYP3A) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsEnhance the exposure of co-administered HIV drugs
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today